Caricamento...
Presynaptic, release‐regulating mGlu(2)‐preferring and mGlu(3)‐preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease
BACKGROUND AND PURPOSE: Presynaptic, release‐regulating metabotropic glutamate 2 and 3 (mGlu(2/3)) autoreceptors exist in the CNS. They represent suitable targets for therapeutic approaches to central diseases that are typified by hyperglutamatergicity. The availability of specific ligands able to d...
Salvato in:
| Pubblicato in: | Br J Pharmacol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831303/ https://ncbi.nlm.nih.gov/pubmed/26791341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13442 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|